Device type · JXK
Cranial Electrotherapy Stimulator To Treat Depression
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JXK
Neurology
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Cranial Electrotherapy Stimulator To Treat Depression
- Product code
- JXK
- Device class
- Class III
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5800
- Specialty
- Neurology & Neurosurgery, Neuromodulation
- FDA record
- Classification database entry for JXK
Latest FDA decisions
- ProlivRx SystemBreakthroughPMA
P250010 · Decided Dec 31, 2025 · 280 days after receipt
Device type: Cranial electrotherapy stimulator to treat depression (JXK) · Neurology & Neurosurgery
- Flow FL-100BreakthroughPMA
P230024 · Decided Dec 8, 2025 · 854 days after receipt
Device type: Cranial electrotherapy stimulator to treat depression (JXK) · Neurology & Neurosurgery
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0712-2008 · Started Oct 29, 2007 · Posted by FDA Apr 8, 2008
Reason given: No FDA clearance for the .35Hz/.45Hz frequency option on device.
Cause as FDA categorized it: Finished device change control
Z-1242-2007 · Started Jul 19, 2007 · Posted by FDA Sep 26, 2007
Reason given: Peak voltage test result not in acceptable limits.
Cause as FDA categorized it: Other
Z-0019-05 · Started Apr 8, 2004 · Posted by FDA Oct 14, 2004
Reason given: Implied claims (extremes of compulsive or addictive behavior) are outside the scope of clearance for the device
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.